Empowering Lives
with improved
drug delivery for
the treatment
of Osteoporosis
Teriparatide is used to treat osteoporosis (a condition in which the bones become thin and weak, hence brittle, and break easily) in women who have undergone menopause ('change in life,' end of menstrual periods), who are at high risk of fractures (broken bones), and cannot use other osteoporosis treatments.
It is also used to increase bone mass in men with certain types of osteoporosis who are at high risk for having broken bones (fractures), and who cannot use other osteoporosis treatments. Teriparatide injection is also used to treat osteoporosis in men and women who are taking corticosteroids (a type of medication that may cause osteoporosis in
some patients) who are at high risk of fractures (broken bones), and cannot use other osteoporosis treatments. Teriparatide injection contains a synthetic form of natural human hormone called parathyroid hormone (PTH). It works by causing the body to build new bone and by increasing bone strength and density (thickness).
Teriparatide is currently sold in injection form, and comes as a solution (liquid) to inject subcutaneously (under the skin) in your thigh or lower stomach area. This medication
comes in prefilled dosing pens. It is usually injected once a day for up to 2 years.
Daily injections for up to 2 years is highly demanding and onerous on users. We have spent that past 7 years developing a Microneedle Patch designed to be easily administered by applying to the skin instead of the use of injections.
Our Unique Patch Technology
Simple, effective, easy to apply.
No more needles.
A single patch applied for a short period of time each day.
For licensing enquiries please email us at:
Licensing@BrittleBoneMedicine.com
For Media related enquiries please contact us at:
PR@BrittleBoneMedicine.com
Brittle Bone Medicine Ltd.,
Loughborough University Science and Enterprise Park
Oakwood Drive,
Loughborough,
Leiestershire,
LE11 3QF, UK
© 2025 Brittle Bone Medicine - All rights reserved | Web Design by
Omniche